Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

SHA:603718 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	246.33	271.02	231.35	294.12	346.15	258.32
Other Revenue	0.02	0.02	9.37	5.87	1.14	0.8
Revenue	246.35	271.04	240.72	299.99	347.29	259.13
Revenue Growth (YoY)	11.70%	12.59%	-19.76%	-13.62%	34.02%	-6.79%
Cost of Revenue	60.34	110.39	120.3	124.61	158.4	140.2
Gross Profit	186.01	160.65	120.42	175.38	188.89	118.93
Selling, General & Admin	69.37	111.95	99.77	126.85	129.9	118.23
Research & Development	24.75	24.45	24.97	29.94	28.64	29.53
Other Operating Expenses	3.22	2.17	1.4	3.33	3.5	2.27
Operating Expenses	99.86	142.12	126.92	159.69	166.99	156.29
Operating Income	86.15	18.53	-6.5	15.69	21.9	-37.36
Interest Expense	-2.59	-5.49	-5.39	-10.31	-12.38	-17.69
Interest & Investment Income	158.61	160.61	75.82	16.43	27.79	23.61
Currency Exchange Gain (Loss)	10.3	10.3	-0.01	-0.06	0.28	1.3
Other Non Operating Income (Expenses)	-35.94	-0.4	-0.29	1.38	-1.61	-0.14
EBT Excluding Unusual Items	216.53	183.55	63.63	23.14	35.99	-30.28
Impairment of Goodwill	-1.19	-1.19	-	-	-	-
Gain (Loss) on Sale of Investments	-9.19	-12.76	-16.52	-2.97	8.28	1.62
Gain (Loss) on Sale of Assets	-0.48	-0.71	0.55	-0.36	7.41	-2.78
Other Unusual Items	39.11	39.22	8.36	111.41	5.46	8.09
Pretax Income	244.78	208.12	56.02	131.22	57.14	-23.34
Income Tax Expense	40.93	26.48	6.01	20.53	11.47	8.81
Earnings From Continuing Operations	203.85	181.64	50.01	110.69	45.67	-32.15
Minority Interest in Earnings	-32.51	-10.46	12.86	10.92	8.19	41.08
Net Income	171.34	171.18	62.87	121.61	53.86	8.93
Net Income to Common	171.34	171.18	62.87	121.61	53.86	8.93
Net Income Growth	1953.15%	172.28%	-48.30%	125.80%	503.33%	-26.54%
Shares Outstanding (Basic)	622	634	629	640	673	893
Shares Outstanding (Diluted)	646	658	629	640	673	893
Shares Change (YoY)	-3.04%	4.72%	-1.77%	-4.93%	-24.58%	46.92%
EPS (Basic)	0.28	0.27	0.10	0.19	0.08	0.01
EPS (Diluted)	0.27	0.26	0.10	0.19	0.08	0.01
EPS Growth	2017.74%	160.00%	-47.37%	137.50%	700.00%	-50.00%
Free Cash Flow	53.75	38.08	-16.18	273.06	5.85	133.56
Free Cash Flow Per Share	0.08	0.06	-0.03	0.43	0.01	0.15
Dividend Per Share	0.078	0.078	0.029	0.057	-	0.004
Dividend Growth	173.17%	173.17%	-49.38%	-	-	-30.00%
Gross Margin	75.50%	59.27%	50.02%	58.46%	54.39%	45.90%
Operating Margin	34.97%	6.84%	-2.70%	5.23%	6.30%	-14.42%
Profit Margin	69.55%	63.16%	26.12%	40.54%	15.51%	3.45%
Free Cash Flow Margin	21.82%	14.05%	-6.72%	91.02%	1.69%	51.54%
EBITDA	120.2	53.27	29.16	56.86	78.79	20.86
EBITDA Margin	48.79%	19.65%	12.11%	18.95%	22.69%	8.05%
D&A For EBITDA	34.06	34.74	35.66	41.17	56.9	58.22
EBIT	86.15	18.53	-6.5	15.69	21.9	-37.36
EBIT Margin	34.97%	6.84%	-2.70%	5.23%	6.30%	-14.42%
Effective Tax Rate	16.72%	12.72%	10.73%	15.64%	20.08%	-
Revenue as Reported	246.35	271.04	240.72	299.99	347.29	259.13
Advertising Expenses	-	3.81	3.22	3.67	3.73	8.4

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.